DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 1 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | – | 24 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 24 | -50.0% | 0.00% | – |
| Q2 2019 | $0 | – | 48 | +6.7% | 0.00% | – |
| Q4 2018 | $0 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 233,730 | $369,293 | 0.45% |
| COOPERMAN LEON G | 812,508 | $1,283,844 | 0.08% |
| CATALYST FINANCIAL PARTNERS LLC | 14,475 | $22,872 | 0.01% |
| Legend Financial Advisors, Inc. | 1,000 | $1,580 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 184,870 | $292 | 0.00% |
| STATE STREET CORP | 133,258 | $210,548 | 0.00% |
| MORGAN STANLEY | 55,201 | $87,223 | 0.00% |
| BlackRock Inc. | 69,937 | $110,508 | 0.00% |
| Bank of New York Mellon Corp | 36,062 | $56,982 | 0.00% |
| Citadel Advisors | 1,600 | $2,528 | 0.00% |